GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
51.02
-1.35 (-2.58%)
At close: Nov 16, 2026, 4:00 PM EST
51.51
+0.49 (0.96%)
After-hours: Nov 16, 2026, 7:47 PM EST

GeneDx Holdings Revenue

GeneDx Holdings had revenue of $123.10M in the quarter ending September 30, 2026, with 5.45% growth. This brings the company's total for the last twelve months to $460.78M, up 14.57% year-over-year. In the year 2025, GeneDx Holdings had annual revenue of $427.54M with 39.97% growth. That makes GeneDx Holdings the 11,733rd largest company in the world by revenue and 2,337th in the United States.

Revenue (ttm)
$460.78M
Revenue Growth
+14.57%
P/S Ratio
3.32
Revenue / Employee
$354,449
Employees
1,300
Market Cap
1.53B

Revenue Chart

Revenue by Segment

  • GeneDx 423.09M 99.0%
  • Fabric Genomics and Legacy Sema4 4.45M 1.0%
Fiscal year ended Dec 31, 2025 See the full GeneDx Holdings breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025427.54M122.09M39.97%
Dec 31, 2024305.45M102.88M50.79%
Dec 31, 2023202.57M-32.13M-13.69%
Dec 31, 2022234.69M22.50M10.60%
Dec 31, 2021212.20M32.87M18.33%
Dec 31, 2020179.32M-16.85M-8.59%
Dec 31, 2019196.17M62.83M47.12%
Dec 31, 2018133.34M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Sotera Health Company1.23B
Myriad Genetics803.60M
NeoGenomics787.75M
OPKO Health654.10M
Veracyte581.78M
CareDx497.40M
Castle Biosciences377.13M
Fulgent Genetics330.28M
Revenue Rankings